Latest Articles

Publication Date
Molecular mechanisms in endometriosis: linking JAK/STAT pathway, ferroptosis, and microbial dysbiosis.

Endometriosis is a chronic gynaecological disorder characterized by ectopic endometrial growth, inflammation, pain, and infertility. Current therapies, largely hormonal and surgical, have limited efficacy and compromise fertility, underscoring the need …

Published: Feb. 14, 2026, midnight
Electroacupuncture alleviates endometriosis by suppressing ferroptosis in murine ectopic and eutopic endometria via the Nrf2 pathway.

Does peritoneal iron overload drive fibrosis in endometriosis through Nrf2 pathway dysfunction and the resulting ferroptosis, and can electroacupuncture intervene in this process?

Published: Feb. 14, 2026, midnight
Natural products modulate programmed cell death signaling mechanism for treating endometriosis: a review.

Endometriosis (EMs) is a gynecological inflammatory disease that depends on estrogen. Its chief symptoms include dysmenorrhea, chronic pelvic pain, reduced fertility, and pelvic masses. Although various hormonal therapies and surgical …

Published: Jan. 29, 2026, midnight
The iron-ferroptosis axis in bone homeostasis: a potential complementary pathway for osteoporosis in endometriosis.

Endometriosis, a chronic gynecological disorder, is clinically associated with an increased risk of osteoporosis. While this link has been primarily attributed to hypoestrogenism resulting from the disease process or its …

Published: Jan. 19, 2026, midnight
The therapeutic potential of pirfenidone in alleviating fibrosis and restoring ovarian function in a novel ovarian endometriosis mouse model.

Published: Jan. 5, 2026, midnight
Involvement of USP33 in ferritinophagy and ferroptosis in endometriosis through the Hippo-YAP pathway.

This study aimed to investigate the mechanism of the involvement of USP33 in autophagic ferroptosis in endometriosis (EMs).

Published: Dec. 26, 2025, midnight
Study Explores DPP4’s Role in Ferroptosis and Endometrial Receptivity in PCOS Patients - geneonline.com

Study Explores DPP4’s Role in Ferroptosis and Endometrial Receptivity in PCOS Patients geneonline.com

Published: Dec. 24, 2025, midnight
Targeting DPP4: Ferroptosis and Endometrial Receptivity in PCOS - BIOENGINEER.ORG

Targeting DPP4: Ferroptosis and Endometrial Receptivity in PCOS BIOENGINEER.ORG

Published: Dec. 23, 2025, 7:31 p.m.
Targeting DPP4: Ferroptosis and Endometrial Receptivity in PCOS - Bioengineer.org

Targeting DPP4: Ferroptosis and Endometrial Receptivity in PCOS Bioengineer.org

Published: Dec. 23, 2025, 7:31 p.m.
EGR1 promotes ferroptosis in endometriosis through transcriptional activation of HMOX1.

Endometriosis (EM) affects approximately 10% of women of reproductive age and remains a prevalent estrogen-dependent gynecological disorder with limited therapeutic efficacy and high recurrence rates. Ferroptosis-an iron-dependent, non-apoptotic form of …

Published: Dec. 19, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!